Addressing Health Disparities in the Care of Advanced Prostate Cancer: An Expert Panel Discussion
This activity is supported by independent educational grants from Astellas Pharma Global Development, Inc.; Lantheus; Merck Sharp & Dohme LLC; and Pfizer Inc.
Overview
Provider Statement
This activity is jointly provided by National Jewish Health and Catamount Medical Education.

Support Statement
This activity is supported by independent educational grants from Astellas Pharma Global Development, Inc.; Lantheus; Merck Sharp & Dohme LLC; and Pfizer Inc.
Release date: November 25, 2024
Expiration date: November 25, 2025
This activity can take up to 45 minutes to complete.
Target Audience
This activity is designed to meet the educational needs of medical oncologists, urologic oncologists, nurse practitioners, physician associates (PAs), and nurses who participate in the management of patients with advanced prostate cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review evidence of health disparities in the care of men with advanced prostate cancer
- Discuss population-specific barriers to optimal care for men with advanced prostate cancer
- Implement strategies and best practices to overcome disparities in the care of men with advanced prostate cancer
Faculty
Stephen J. Freedland, MD
Professor of Urology, Cedars-Sinai Medical Center
Staff Physician, Durham VA Medical Center
Durham, NC
Bassel Nazha, MD, MPH
Assistant Professor – GU Medical Oncology
Associate Section Chief – Hematology Oncology Winship Midtown
Winship Cancer Institute of Emory University
Atlanta, GA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of National Jewish Health and Catamount Medical Education. National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
National Jewish Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other health care professionals completing this course will be issued a statement of participation.
How to Participate in this Activity and Obtain CE credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
1) Read the CE information
2) Complete the pretest
3) View the video
4) Complete the posttest and the evaluation form
A score of 75% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Following the posttest and evaluation form your certificate will be made available immediately.
Faculty and Disclosure of Conflicts of Interest
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Faculty Disclosures
The program faculty reported the following relevant financial relationships with ineligible companies:
Stephen J. Freedland, MD
Consultant: Astellas Pharma Inc.; AstraZeneca; Bayer; Janssen Pharmaceuticals; Merck Sharp & Dohme LLC; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sanofi
Speaker: Astellas Pharma Inc.; AstraZeneca; Pfizer Inc
Advisory Board: Astellas Pharma Inc.; Bayer; Lilly USA, LLC; Pfizer Inc
Bassel Nazha, MD, MPH
Consultant: Cardinal Health; Exelixis, Inc.; IntrinsiQ Specialty Solutions; NeoGenomics Laboratories
Advisory Board: Cardinal Health; Exelixis, Inc.; IntrinsiQ Specialty Solutions; NeoGenomics Laboratories
Investigator: Astellas Pharma Inc.; Merck Sharp & Dohme LLC; Seagen/Pfizer Inc; Xencor
Planners and Independent Reviewers
Susan Denner, MD, MS
Chief Medical Officer
Catamount Medical Education
Disclosure: Dr. Denner has reported no relevant financial relationships.
Alexa Lasek
Project Manager
Catamount Medical Education
Disclosure: Ms. Lasek has reported no relevant financial relationships.
Meghan Brenner, MA
Associate Director, Accreditation and Programs
National Jewish Health
Disclosure: Ms. Brenner has reported no relevant financial relationships.
Laniecia Demmer
Professional Education Programs Coordinator
National Jewish Health
Disclosure: Ms. Demmer has reported no relevant financial relationships.
Andrea Harshman, MHA, CHCP, CMP-HC
Director, Office of Professional Education
National Jewish Health
Disclosure: Ms. Harshman has reported no relevant financial relationships.
Jordan Chauncey, FNP
Oncology Nurse Practitioner
National Jewish Health
Disclosure: Ms. Chauncey has reported no relevant financial relationships.
Zulma Yunt, MD
Associate Professor
Medical Director, Office of Professional Education
National Jewish Health
Disclosure:
Speaker: Boehringer Ingelheim
Our Policy on Privacy
The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME).
We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.
If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities. https://www.nationaljewish.org/education/pro-ed/policies
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussion of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications, and warnings.
Disclaimer
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course, or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course, or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.